Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $36.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 17.95% year-over-year to $36.1 million; the TTM figure through Mar 2026 stood at $36.1 million (down 17.95% YoY), while the FY2025 annual figure was $36.5 million, down 30.47% from the prior year.
• Other Non-Current Liabilities was $36.1 million for Q1 2026 at Maravai Lifesciences Holdings, down from $36.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $66.5 million in Q1 2022 to a low of $10.0 million in Q4 2022.
• Historically, Other Non-Current Liabilities has averaged $50.0 million across 5 years, with a median of $54.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities soared 4686.19% in 2022, then tumbled 30.47% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $10.0 million in 2022, then soared by 494.94% to $59.5 million in 2023, then fell by 11.81% to $52.5 million in 2024, then tumbled by 30.47% to $36.5 million in 2025, then decreased by 1.11% to $36.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $36.1 million (Q1 2026), $36.5 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.